von Hippel-Lindau gene-mediated growth suppression and induction of differentiation in renal cell carcinoma cells grown as multicellular tumor spheroids

Cancer Research

Volumn 58, Issue 21, 1998, Pages 4957-4962

  Lieubeau Teillet, Blandine ^a,b   Rak, Janusz ^a,b   Jothy, Serge ^a,b   Iliopoulos, Othon ^c   Kaelin, William ^c,d   Kerbel, Robert S ^a,b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; GENETIC TRANSFECTION; GROWTH INHIBITION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; MORPHOGENESIS; ONCOGENE RAS; PRIORITY JOURNAL; SOLID TUMOR; SPHEROID CELL; TUMOR SUPPRESSOR GENE; VON HIPPEL LINDAU DISEASE;

ANIMALS; CARCINOMA, RENAL CELL; CELL DIFFERENTIATION; CELLS, CULTURED; FIBRONECTINS; GENES, RAS; GENES, TUMOR SUPPRESSOR; KIDNEY NEOPLASMS; LIGASES; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; PROTEINS; SPHEROIDS, CELLULAR; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 0032211360     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Iliopoulos, O., and Kaelin, W. G., Jr. The molecular basis of von Hippel-Lindau disease. Mol. Med., 3: 289-293, 1997.
2. Neumann, H. P., and Zbar, B. Renal cysts, renal cancer and von Hippel-Lindau disease. Kidney Int., 51: 16-26, 1997.
3. Iliopoulos, O., Kibel, A., Gray, S., and Kaelin, W. G., Jr. Tumour suppression by the human von Hippel-Lindau gene product. Nat. Med., 1: 822-826, 1995.
4. Gnarra, J. R., Zhou, S., Merrill, M. J., Wagner, J. R., Krumm, A., Papavassiliou, E., Oldfield, E. H., Klausner, R. D., and Linehan, W. M. Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene. Proc. Natl. Acad. Sci. USA, 93: 10589-10594, 1996.
5. Chen, F., Kishida, T., Duh, F. M., Renbaum, P., Orcutt, M. L., Schmidt, L., and Zbar, B. Suppression of growth of renal carcinoma cells by the von Hippel-Lindau tumor suppressor gene. Cancer Res., 55: 4804-4807, 1995.
6. Pause, A., Lee, S., Lonergan, K. M., and Klausner, R. D. The von Hippel-Lindau tumor suppressor gene is required for cell cycle exit upon serum withdrawal. Proc. Natl. Acad. Sci. USA, 95: 993-998, 1998.
7. Levy, A. P., Levy, N. S., Iliopoulos, O., Jiang, C., Kaplin, W. G., Jr., and Goldberg, M. A. Regulation of vascular endothelial growth factor by hypoxia and its modulation by the von Hippel-Lindau tumor suppressor gene. Kidney Int., 51: 575-578, 1997.
8. Siemeister, G., Weindel, K., Mohrs, K., Barleon, B., Martiny-Baron, G., and Marme, D. Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein. Cancer Res., 56: 2299-2301, 1996.
9. Pal, S., Claffey, K. P., Dvorak, H. F., and Mukhopadhyay, D. The von Hippel-Lindau gene product inhibits vascular permeability factor/vascular endothelial growth factor expression in renal cell carcinoma by blocking protein kinase C pathways. J. Biol. Chem., 272: 27509-27512, 1997.
10. Dvorak, H. F., Brown, L. F., Detmar, M., and Dvorak, A. M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol., 146: 1029-1039, 1995.
11. Duan, D. R., Humphrey, J. S., Chen, D. Y., Weng, Y., Sukegawa, J., Lee, S., Gnarra, J. R., Linehan, W. M., and Klausner, R. D. Characterization of the VHL tumor suppressor gene product: localization, complex formation, and the effect of natural inactivating mutations. Proc. Natl. Acad. Sci. USA, 92: 6459-6463, 1995.
12. Lee, S., Chen, D. Y. T., Humphrey, J. S., Gnarra, J. R., Linehan, W. M., and Klausner, R. D. Nuclear/cytoplasmic localization of the von Hippel-Lindau tumor suppressor gene product is determined by cell density. Proc. Natl. Acad. Sci. USA, 93: 1770-1775, 1996.
13. Sutherland, R. M. Cell and environment interactions in tumor microregions: the multicell spheroid model. Science (Washington DC), 240: 177-184, 1988.
14. Knuechel, R., and Sutherland, R. M. Cell differentiation and heterogeneity in spheroid culture. In: R. Bjerkvig (ed.), Spheroid Culture in Cancer Research, pp. 159-170. Boca Raton, FL: CRC Press, 1992.
15. Goodwin, T. J., Jessup, J. M., and Wolf, D. A. Morphologic differentiation of colon carcinoma cell lines HT-29 and HT-29KM in rotating-wall vessels. In Vitro Cell. Dev. Biol., 28A: 47-60, 1992.
16. Sacks, P. G., Oke, V., Amos, B., Vasey, T., and Lotan, R. Modulation of growth, differentiation and glycoprotein synthesis by β-all-trans-retinoic acid in a multicellular tumor spheroid model for squamous carcinoma of the head and neck. Int. J. Cancer, 44: 926-933, 1989.
17. Knuechel, R., Keng, P., Hofstaedter, F., Langmuir, V., Sutherland, R. M., and Penney, D. P. Differentiation patterns in two- and three-dimensional culture systems of human squamous carcinoma cell lines. Am. J. Pathol., 137: 725-736, 1990.
18. Glimelius, B., Norling, B., Nederman, T., and Carlsson, J. Extracellular matrices in multicellular spheroids of human glioma origin: increased incorporation of proteoglycans and fibronectin as compared to monolayer cultures. Acta Pathol. Microbiol. Scand., 96: 433-444, 1988.
19. Rak, J., Mitsuhashi, Y., Erdos, V., Huang, S-N., Filmus, J., and Kerbel, R. S. Massive programmed cell death in intestinal epithelial cells induced by three-dimensional growth conditions: suppression by expression of a mutant c-H-ras oncogene. J. Cell Biol., 131: 1587-1598, 1995.
20. Kobayashi, H., Man, S., Kapitain, S. J., Teicher, B. A., and Kerbel, R. S. Acquired multicellular-mediated resistance to alkylating agents in cancer. Proc. Natl. Acad. Sci. USA, 90: 3294-3298, 1993.
21. St. Croix, B., Rak, J. W., Kapitain, S., Sheehan, C., Graham, C. H., and Kerbel, R. S. Reversal by hyaluronidase of adhesion-dependent multicellular drug resistance in mammary carcinoma cells. J. Natl. Cancer Inst. (Bethesda), 88: 1285-1296, 1996.
22. Kip1 on adhesion-dependent resistance of tumor cells to anticancer agents. Nat. Med., 2: 1204-1210, 1996.
23. Theodorescu, D., Caltabiano, M., Greig, R., Rieman, D., and Kerbel, R. S. Reduction of TGF-β activity abrogates growth promoting tumor cell-cell interactions in vivo. J. Cell Physiol., 148: 380-390, 1991.
24. Rak, J. W., and Kerbel, R. S. Growth advantage ("clonal dominance") of metastatically-competent tumor cell variants expressed under selective two or three dimensional tissue culture conditions. In Vitro Cell. Dev. Biol., 29A: 742-748, 1993.
25. Ohh, M., Yauch, R. L., Lonergan, K. M., Whaley, J. M., Stemmer-Rachamimov, A. O., Louis, D. N., Gavin, B. J., Kley, N., Kaelin, W. G., Jr., and Iliopoulos, O. The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix. Mol. Cell, 7: 959-968, 1998.
26. Lohi, J., Tani, T., Laitinen, L., Kangas, L., Lehto, V. P., and Virtanen, I. Tenascin and fibronectin isoforms in human renal cell carcinomas, renal cell carcinoma cell lines and xenografts in nude mice. Int. J. Cancer, 63: 442-449, 1995.
27. Rahilly, M. A., Salter, D. M., and Fleming, S. Composition and organization of cell-substratum contacts in normal and neoplastic renal epithelium. J. Pathol., 165: 163-171, 1991.
28. Singh, R. K., Gutman, M., Bucana, C. D., Sanchez, R., Llansa, N., and Fidler, I. J. Interferons α and β down-regulate the expression of basic fibroblast growth factor in human carcinomas. Proc. Natl. Acad. Sci. USA, 92: 4562-4566, 1995.
29. Brown, L. F., Berse, B., Jackman, R. W., Tognazzi, K., Manseau, E. J., Dvorak, H. F., and Senger, D. R. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am. J. Pathol., 143: 1255-1262, 1993.